{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:20:58Z","timestamp":1792102858863,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ijpharm.2018.10.033","type":"journal-article","created":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T07:46:41Z","timestamp":1539244001000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma"],"prefix":"10.1016","volume":"553","author":[{"given":"Quansheng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-9374","authenticated-orcid":false,"given":"Xiangrong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.10.033_b0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","article-title":"Liposomes in topical ophthalmic drug delivery: an update","volume":"23","author":"Agarwal","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.eye.6701428","article-title":"Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination","volume":"19","author":"Akman","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J. Control. Rel.: Off. J. Control. Rel. Soc."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/08982104.2013.788026","article-title":"Novel tretinoin formulations: a drug-in-cyclodextrin-in-liposome approach","volume":"23","author":"Ascenso","year":"2013","journal-title":"J. Lipos. Res."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0025","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/mabi.201200017","article-title":"Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility","volume":"12","author":"Bauer","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ICO.0000000000000699","article-title":"Transepithelial corneal cross-linking with vitamin E-enhanced riboflavin solution and abbreviated, low-dose UV-A: 24-month clinical outcomes","volume":"35","author":"Caruso","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-014-0244-2","article-title":"Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery","volume":"16","author":"Cholkar","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0040","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1208\/s12249-014-0159-y","article-title":"Optimization of dexamethasone mixed nanomicellar formulation","volume":"15","author":"Cholkar","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0045","author":"Cholkar","year":"2014","journal-title":"Ocular Drug Delivery"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2005.11.005","article-title":"Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers","volume":"111","author":"Collnot","year":"2006","journal-title":"J. Control. Rel. Off. J. Control. Rel. Soc."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0055","series-title":"Ocular Pharmacokinetics, Anonymous Pharmacology of the Eye","first-page":"19","author":"Maurice","year":"1984"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0060","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1167\/iovs.02-1142","article-title":"Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines","volume":"44","author":"Dey","year":"2003","journal-title":"Investig. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/jop.1992.8.151","article-title":"Precorneal sampling techniques for ophthalmic gels","volume":"8","author":"Ding","year":"1992","journal-title":"J. Ocular Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.colsurfb.2015.02.007","article-title":"Novel in situ gel systems based on P123\/TPGS mixed micelles and gellan gum for ophthalmic delivery of curcumin","volume":"128","author":"Duan","year":"2015","journal-title":"Colloid. Surf. B Biointerf."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0075","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1016\/j.ces.2007.08.006","article-title":"Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo","volume":"62","author":"Feng","year":"2007","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000342196","article-title":"The effects of topical coenzyme Q10 and vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate after cataract surgery: a clinical and in vivo confocal study. Ophthalmologica","volume":"229","author":"Fogagnolo","year":"2013","journal-title":"J. int. d'ophtalmol. Int. J. Ophthalmol. Zeitsch. Augen."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejps.2013.02.006","article-title":"The applications of Vitamin E TPGS in drug delivery","volume":"49","author":"Guo","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt0801001","article-title":"Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies","volume":"8","author":"Hathout","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2147\/IJN.S30725","article-title":"Liposomes and nanotechnology in drug development: focus on ocular targets","volume":"8","author":"Honda","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/jop.2006.22.110","article-title":"Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea","volume":"22","author":"Katragadda","year":"2006","journal-title":"J. Ocul. Pharmacol. Therapeut. Off. J. Assoc. Ocular Pharmacol. Therapeut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0105","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08982104.2016.1191022","article-title":"Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation","volume":"27","author":"Khalil","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj1860591","article-title":"Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro","volume":"186","author":"Kirby","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2016.08.024","article-title":"Light activated liposomes: Functionality and prospects in ocular drug delivery","volume":"244","author":"Lajunen","year":"2016","journal-title":"J. Control. Rel. Off. J. Control. Rel. Soc."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0120","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","article-title":"Liposomes as a novel ocular delivery system for brinzolamide. in vitro and in vivo studies","volume":"17","author":"Li","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2016.08.037","article-title":"Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: an in vivo\/in vitro evaluation","volume":"512","author":"Li","year":"2016","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2013.03.024","article-title":"Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac","volume":"448","author":"Li","year":"2013","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10717544.2014.903535","article-title":"Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium","volume":"23","author":"Luo","year":"2016","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1166\/jbn.2009.1050","article-title":"Haemolytic activity of liposomes: effect of vesicle size, lipid concentration and polyethylene glycol-lipid or arsonolipid incorporation","volume":"5","author":"Mourtas","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2005.08.026","article-title":"Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin","volume":"306","author":"Mu","year":"2005","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0150","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1271\/bbb.56.1472","article-title":"A modified colorimetric MTT assay adapted for primary cultured hepatocytes: application to proliferation and cytotoxicity assays","volume":"56","author":"Oka","year":"1992","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2012.09.051","article-title":"Enhancement of corneal permeation of riboflavin-5'-phosphate through vitamin E TPGS: a promising approach in corneal trans-epithelial cross linking treatment","volume":"440","author":"Ostacolo","year":"2013","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0160","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/17425247.2013.777425","article-title":"Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel","volume":"10","author":"Raju","year":"2013","journal-title":"Exp. Opinion Drug Deliv."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/0250-474X.65014","article-title":"Design and evaluation of liposomal formulation of pilocarpine nitrate","volume":"72","author":"Rathod","year":"2010","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0170","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/0024-3205(82)90455-6","article-title":"Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components","volume":"30","author":"Senior","year":"1982","journal-title":"Life Sciences"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bjo.2007.125187","article-title":"A comparative study of the effects of brinzolamide and dorzolamide on retinal oxygen saturation and ocular microcirculation in patients with primary open-angle glaucoma","volume":"92","author":"Siesky","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0180","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1080\/10717544.2017.1406561","article-title":"Recent developments in d-alpha-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy","volume":"24","author":"Tan","year":"2017","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jop.2013.0157","article-title":"Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility","volume":"30","author":"Vadlapudi","year":"2014","journal-title":"J. Ocular Pharmacol. Therapeut. Off. J. Assoc. Ocular Pharmacol. Therapeut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0190","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1002\/jps.21383","article-title":"PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions","volume":"97","author":"Vega","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0195","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157016212803901383","article-title":"Gold nanoparticles as an HIV entry inhibitor","volume":"10","author":"Vijayakumar","year":"2012","journal-title":"Current HIV Res."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2018.00091","article-title":"Nanoliposome-encapsulated brinzolamide-hydropropyl-beta-cyclodextrin inclusion complex: a potential therapeutic ocular drug-delivery system","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.colsurfb.2014.07.004","article-title":"Dorzolamide-loaded PLGA\/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits","volume":"122","author":"Warsi","year":"2014","journal-title":"Colloids Surf. B, Biointerfaces"},{"key":"10.1016\/j.ijpharm.2018.10.033_b0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2008.11.021","article-title":"Inhibiting efflux with novel non-ionic surfactants: rational design based on vitamin E TPGS","volume":"370","author":"Wempe","year":"2009","journal-title":"Int. J. Pharmaceut."},{"key":"10.1016\/j.ijpharm.2018.10.033_b0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1099-1263(199807\/08)18:4<233::AID-JAT496>3.0.CO;2-Y","article-title":"A critical review of the assessment of eye irritation potential using the Draize rabbit eye test","volume":"18","author":"York","year":"1998","journal-title":"J. Appl. Toxicol. JAT"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318307683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318307683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T20:12:11Z","timestamp":1605211931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318307683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0378517318307683"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.10.033","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}